Global Dilated Cardiomyopathy Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drug Class;

Aldosterone antagonists, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers (ARBs) and Beta-blockers.

Segmented by Pipeline Drugs;

ARRY-797, ixCELL-DCM, MYDICAR, OR-1 and CAP-1002.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn363896699 Published Date: April, 2022 Updated Date: May, 2022

Introduction

Global Dilated Cardiomyopathy Therapeutics Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 112.2
2019 124.8
2020 125.5
2021 142.1
2022 144.8
2023 172.7
2024 196.9
2025 203.2
2026 231.8
2027 268.5
2028 311.2

In the year 2021, the Global Dilated Cardiomyopathy Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Pipeline Drugs
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Dilated Cardiomyopathy Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing number of heart failure cases worldwide will lead to rise in demand for effective medications, thereby driving market growth
      2. Restraints
        1. Side effects associated with DCM drugs could restrain market growth
        2. Enhanced relief from use of devices without any side effects will restrain the dilated cardiomyopathy drugs market
      3. Opportunities
        1. Increasing genericization of DCM drugs
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Dilated Cardiomyopathy Therapeutics Market, By Drug Class, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Aldosterone antagonists
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Angiotensin-converting enzyme (ACE) inhibitors
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Angiotensin II receptor blockers (ARBs)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Beta-blockers
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Dilated Cardiomyopathy Therapeutics Market, By Pipeline Drugs, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. ARRY-797
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. ixCELL-DCM
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. MYDICAR
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. OR-1
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. CAP-1002
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Dilated Cardiomyopathy Therapeutics Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Pipeline Drugs, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Array BioPharma, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. AstraZeneca plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Celladon Corporation
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. GlaxoSmithKline plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Janssen Pharmaceuticals, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Merck & Co., Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Novartis International AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Pfizer, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Sanofi S.A.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Teva Pharmaceutical Industries Ltd.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      11. Vericel Corporation
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Diphenhydramine
Global Diphenhydramine Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Diphenhydramine Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Display Driver IC
Global Display Driver IC Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Display Driver IC Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Disposable Hospital Supplies
Global Disposable Hospital Supplies Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Disposable Hospital Supplies Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Disposable Lancets
Global Disposable Lancets Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Disposable Lancets Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...